Fulvestrant (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fulvestrant" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

4^th place

8^th place

2^nd place

5^th place

low place

607^th place

low place

34^th place

1books.google.com

3^rd place

11^th place

447^th place

409^th place

399^th place

169^th place

68^th place

28^th place

1medicines.org.uk

3,823^rd place

3,244^th place

books.google.com

Dörwald, Florencio Zaragoza (4. februar 2013). Lead Optimization for Medicinal Chemists: Pharmacokinetic Properties of Functional Groups and Organic Compounds. John Wiley & Sons. str. 486–. ISBN 978-3-527-64565-7.

cbz.si

http://www.cbz.si/cbz/bazazdr2.nsf/Search?SearchView&Query=(%5BJENALISTI%5D=1)+(%5BSEZNAMUCINKNAZIV%5D=_fulvestrant*)&SearchOrder=4&SearchMax=301 Centralna baza zdravil, vpogled: 10. 10. 2021.

doi.org

Lee CI, Goodwin A, Wilcken N (Januar 2017). »Fulvestrant for hormone-sensitive metastatic breast cancer«. The Cochrane Database of Systematic Reviews. 1: CD011093. doi:10.1002/14651858.CD011093.pub2. PMC 6464820. PMID 28043088.
Lai AC, Crews CM (Februar 2017). »Induced protein degradation: an emerging drug discovery paradigm«. Nature Reviews. Drug Discovery. 16 (2): 101–114. doi:10.1038/nrd.2016.211. PMC 5684876. PMID 27885283.

drugs.com

»Fulvestrant«. The American Society of Health-System Pharmacists. Pridobljeno 8. januarja 2017.

europa.eu

ema.europa.eu

»Faslodex«. Evropska agencija za zdravila. Pridobljeno 10. oktobra 2021.

fda.gov

accessdata.fda.gov

»US Label: Fulvestrant« (PDF). FDA. Julij 2016.

medicines.org.uk

»Faslodex 250 mg solution for injection - Summary of Product Characteristics«. UK Electronic Medicines Compendium. 21. julij 2016.

nih.gov

ncbi.nlm.nih.gov

Lee CI, Goodwin A, Wilcken N (Januar 2017). »Fulvestrant for hormone-sensitive metastatic breast cancer«. The Cochrane Database of Systematic Reviews. 1: CD011093. doi:10.1002/14651858.CD011093.pub2. PMC 6464820. PMID 28043088.
Lai AC, Crews CM (Februar 2017). »Induced protein degradation: an emerging drug discovery paradigm«. Nature Reviews. Drug Discovery. 16 (2): 101–114. doi:10.1038/nrd.2016.211. PMC 5684876. PMID 27885283.

pubmed.ncbi.nlm.nih.gov

Lee CI, Goodwin A, Wilcken N (Januar 2017). »Fulvestrant for hormone-sensitive metastatic breast cancer«. The Cochrane Database of Systematic Reviews. 1: CD011093. doi:10.1002/14651858.CD011093.pub2. PMC 6464820. PMID 28043088.
Lai AC, Crews CM (Februar 2017). »Induced protein degradation: an emerging drug discovery paradigm«. Nature Reviews. Drug Discovery. 16 (2): 101–114. doi:10.1038/nrd.2016.211. PMC 5684876. PMID 27885283.

termania.net

https://www.termania.net/slovarji/slovenski-medicinski-slovar/5516117/fulvestrant?query=fulvestrant&SearchIn=All Slovenski medicinski e-slovar, vpogled: 10. 10. 2021.